The Human CDK8 Subcomplex is a Molecular Switch That Controls Mediator Coactivator Function
Overview
Affiliations
The human CDK8 subcomplex (CDK8, cyclin C, Med12, and Med13) negatively regulates transcription in ways not completely defined; past studies suggested CDK8 kinase activity was required for its repressive function. Using a reconstituted transcription system together with recombinant or endogenous CDK8 subcomplexes, we demonstrate that, in fact, Med12 and Med13 are critical for subcomplex-dependent repression, whereas CDK8 kinase activity is not. A hallmark of activated transcription is efficient reinitiation from promoter-bound scaffold complexes that recruit a series of pol II enzymes to the gene. Notably, the CDK8 submodule strongly represses even reinitiation events, suggesting a means to fine tune transcript levels. Structural and biochemical studies confirm the CDK8 submodule binds the Mediator leg/tail domain via the Med13 subunit, and this submodule-Mediator association precludes pol II recruitment. Collectively, these results reveal the CDK8 subcomplex functions as a simple switch that controls the Mediator-pol II interaction to help regulate transcription initiation and reinitiation events. As Mediator is generally required for expression of protein-coding genes, this may reflect a common mechanism by which activated transcription is shut down in human cells.
Central control of dynamic gene circuits governs T cell rest and activation.
Arce M, Umhoefer J, Arang N, Kasinathan S, Freimer J, Steinhart Z Nature. 2024; 637(8047):930-939.
PMID: 39663454 PMC: 11754113. DOI: 10.1038/s41586-024-08314-y.
The MED13L Foundation strategic research plan: a roadmap to the future.
Heilmann R, Pfalzer A, Bichell T, Terala A, Campbell A, Taatjes D Ther Adv Rare Dis. 2024; 5:26330040241290252.
PMID: 39619418 PMC: 11605767. DOI: 10.1177/26330040241290252.
Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module.
Chao T, Chen S, Kim H, Tang H, Tseng H, Xu A Mol Cell. 2024; 84(20):3932-3949.e10.
PMID: 39321804 PMC: 11832219. DOI: 10.1016/j.molcel.2024.09.001.
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer.
Andolfi C, Bartolini C, Morales E, Gundogdu B, Puhr M, Guzman J Endocrinology. 2024; 165(10).
PMID: 39253786 PMC: 11398899. DOI: 10.1210/endocr/bqae114.
Structures and compositional dynamics of Mediator in transcription regulation.
Li T, Chao T, Tsai K Curr Opin Struct Biol. 2024; 88:102892.
PMID: 39067114 PMC: 11779508. DOI: 10.1016/j.sbi.2024.102892.